-
Chemoimmunotherapy is
chemotherapy combined with immunotherapy.
Chemotherapy uses
different drugs to kill or slow the
growth of
cancer cells; immunotherapy...
- to first-line
chemoimmunotherapy or
relapse within 12
months of first-line
chemoimmunotherapy; or
disease to first-line
chemoimmunotherapy or
relapse after...
-
Pathologic Response in
Patients with
NSCLC Receiving Neoadjuvant Chemoimmunotherapy".
Clinical Cancer Research. 27 (21): 5878–5890. doi:10.1158/1078-0432...
-
signs or symptoms,
treat can
involve chemotherapy, immunotherapy, or
chemoimmunotherapy. The most
appropriate treatment is
based on the individual's age,...
- Stephan; Webb, David; Janka, Gritta; Henter, Jan-Inge (2011-10-27). "
Chemoimmunotherapy for
hemophagocytic lymphohistiocytosis: long-term
results of the HLH-94...
- fludarabine, cyclophosphamide, and mitoxantrone: a new,
highly active chemoimmunotherapy regimen for
chronic lymphocytic leukemia".
Journal of
Clinical Oncology...
-
pneumonitis development in non-small-cell lung
cancer patients receiving chemoimmunotherapy from
NADIM trial".
Journal for
Immunotherapy of Cancer. 9 (8): e002804...
- that is
refractory to first-line
chemoimmunotherapy or
relapses within twelve months of first-line
chemoimmunotherapy. It is not
indicated for the treatment...
-
mantle cell
lymphoma (MCL), with or
without prior rituximab-containing
chemoimmunotherapy treatment, is
bendamustine with
mitoxantrone and rituximab. In Germany...
-
absence of 17p
deletion or TP53
mutation in
adults who have
failed both
chemoimmunotherapy and a B cell
receptor pathway inhibitor.
Venetoclax is also indicated...
